LIFESPAN TECHNOLOGIES LLC

Medtech

PEth ELISA diagnostic assay for detecting chronic alcohol use via phosphatidylethanol biomarker in blood

Grants
$399K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Innovative Point-of-Care Solutions for Long-term Alcohol Biomarkers$399,293
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
702HONEYCOMB BIOTECHNOLOGIES INC——
703NOVA Thin Film Pharmaceuticals LLC——
704COMPUTER TECHNOLOGY ASSOCIATES, INC.——
705LIFESPAN TECHNOLOGIES LLC——
706NANOMETICS LLC——
707SAFELYYOU, INC.——
708APTAMATRIX, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.